K2 Principal Fund’s Immunomedics Inc IMMU Stock Holding History

K2 Principal Fund’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-17,582	Closed	-$1.5M	–	436
2020 Q3	$1.5M	Buy	+17,582	New	+$889K	0.22%	130

K2 Principal Fund's IMMU Position: Q4 2020 in Review

K2 Principal Fund sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 17,582 shares — an estimated $1.5M sold.

K2 Principal Fund first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $1.5M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

K2 Principal Fund reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
K2 Principal Fund sold 17,582 Immunomedics Inc shares in Q4 2020, an estimated $1.5M.
K2 Principal Fund first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
K2 Principal Fund's Immunomedics Inc position peaked at $1.5M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on K2 Principal Fund's 13F filing for Q4 2020, filed 12 Feb 2021.